170 related articles for article (PubMed ID: 20213737)
1. Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance.
Baruah P; Simpson E; Dumitriu IE; Derbyshire K; Coe D; Addey C; Dyson J; Chai JG; Cook T; Scott D; Botto M
Eur J Immunol; 2010 Jun; 40(6):1758-67. PubMed ID: 20213737
[TBL] [Abstract][Full Text] [Related]
2. Transplantation tolerance induced by intranasal administration of HY peptides.
Chai JG; James E; Dewchand H; Simpson E; Scott D
Blood; 2004 May; 103(10):3951-9. PubMed ID: 14726386
[TBL] [Abstract][Full Text] [Related]
3. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.
Derbyshire K; Addey C; Coe D; Stuckey DW; Muezzin H; Bubier JA; Shaffer DJ; Roopenian DC; Chai JG; Scott DM
J Immunol; 2011 May; 186(10):5719-28. PubMed ID: 21490154
[TBL] [Abstract][Full Text] [Related]
5. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.
Sireci G; Barera A; Macaluso P; Di Sano C; Bonanno CT; Pio La Manna M; Di Liberto D; Dieli F; Salerno A
Immunobiology; 2009; 214(8):703-11. PubMed ID: 19249121
[TBL] [Abstract][Full Text] [Related]
6. Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency.
Fossati-Jimack L; Ling GS; Baudino L; Szajna M; Manivannan K; Zhao JC; Midgley R; Chai JG; Simpson E; Botto M; Scott D
Immunology; 2015 Jan; 144(1):149-57. PubMed ID: 25039245
[TBL] [Abstract][Full Text] [Related]
7. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
8. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells.
Zelenika D; Adams E; Mellor A; Simpson E; Chandler P; Stockinger B; Waldmann H; Cobbold SP
J Immunol; 1998 Aug; 161(4):1868-74. PubMed ID: 9712055
[TBL] [Abstract][Full Text] [Related]
9. The role of direct presentation by donor dendritic cells in rejection of minor histocompatibility antigen-mismatched skin and hematopoietic cell grafts.
Fernandes E; Goold HD; Kissenpfennig A; Malissen B; Dyson J; Bennett CL
Transplantation; 2011 Jan; 91(2):154-60. PubMed ID: 21085063
[TBL] [Abstract][Full Text] [Related]
10. Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues.
Coe D; Addey C; White M; Harwood N; Dyson J; Chai JG
Cancer Immunol Immunother; 2013 Jan; 62(1):101-12. PubMed ID: 22806093
[TBL] [Abstract][Full Text] [Related]
11. Biphasic expression and cytokine regulation of the complement C3 in heart allograft.
Wu W; Wang HD; He P; Zhang YJ; Yang K; Hua X
Transpl Immunol; 2011 Jan; 24(2):131-7. PubMed ID: 20970501
[TBL] [Abstract][Full Text] [Related]
12. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen.
Valujskikh A; Matesic D; Heeger PS
Transplantation; 1999 Oct; 68(7):1029-36. PubMed ID: 10532546
[TBL] [Abstract][Full Text] [Related]
13. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
14. Prolonged Hya-disparate skin graft survival in ethanol-consuming mice: correlation with impaired delayed hypersensitivity.
Wang K; Busker-Mannie AE; Hoeft J; Vasquez K; Miller SD; Melvold RW; Waltenbaugh C
Alcohol Clin Exp Res; 2001 Oct; 25(10):1542-8. PubMed ID: 11696676
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers.
Maile R; Wang B; Schooler W; Meyer A; Collins EJ; Frelinger JA
J Immunol; 2001 Oct; 167(7):3708-14. PubMed ID: 11564786
[TBL] [Abstract][Full Text] [Related]
16. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
[TBL] [Abstract][Full Text] [Related]
17. Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.
Kwun J; Malarkannan S; Burlingham WJ; Knechtle SJ
J Immunol; 2011 Oct; 187(8):3997-4006. PubMed ID: 21900176
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells.
Oberbarnscheidt MH; Obhrai JS; Williams AL; Rothstein DM; Shlomchik WD; Chalasani G; Lakkis FG
Am J Transplant; 2010 Jan; 10(1):162-7. PubMed ID: 19951284
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
Coley SM; Ford ML; Hanna SC; Wagener ME; Kirk AD; Larsen CP
J Immunol; 2009 Jan; 182(1):225-33. PubMed ID: 19109153
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
